2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$131.00+$1.11 (+0.85%)
Price as of Jul 14, 2026 5:39 AM EDT- $8.4BMarket Cap
- 135.18%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$131.00+$1.11 (+0.85%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $129.89 | ||
Change | -$1.53 (-1.16%) | ||
Open | $130.05 | ||
High | $131.36 | ||
Low | $125.32 | ||
Previous Close | $131.42 | ||
Volume | 541,062 | ||
30-Day Average Volume | 983,064 | ||
1-Week Change | -1.22% | ||
1-Month Change | 18.32% | ||
1-Year Change | 135.18% | ||
3-Year Change | 507.10% | ||
5-Year Change | 181.63% | ||
Fundamentals | |||
Shares Outstanding | 64.3M | ||
Total Assets | $697.5M | ||
Market Cap | $8.4B | ||
Enterprise Value | $8.2B | ||
Period: QTR TTM FY | |||
Revenue | $56.4M | ||
Net Income | $3.8M | ||
Free Cash Flow | -$49.2M | ||
EBIT | $2.3M | ||
EBITDA | $2.7M | ||
Net Working Capital | $578.9M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 3,036 | ||
Enterprise Value/Revenue | 145 | ||
P/B | 13 | ||
P/E | 2,598 | ||
PEG | 24 | ||
Price/Free Cash Flow | -170 | ||
Price/Operating Cash Flow | -171 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue